Abvc biopharma, inc. announces new ceo as it targets further growth

Fremont, ca, june 26, 2023 (globe newswire) -- via newmediawire -- abvc biopharma, inc. (nasdaq: abvc), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, cns, and ophthalmology, today announced the appointment of dr. uttam yashwant patil (dr. uttam) as the new chief executive officer (ceo).
ABVC Ratings Summary
ABVC Quant Ranking